Quantum Biopharma Ltd. Files September 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Sep 29, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (formerly FSD Pharma) filed its monthly 6-K, confirming 20-F annual report filings.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on September 29, 2025, reporting for the month of September 2025. The company, formerly known as FSD Pharma Inc. until March 27, 2019, is based in Toronto, Ontario, Canada. This filing indicates they are a foreign private issuer and will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's status as a foreign private issuer and its reporting schedule.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- 20250929 (date) — Filing date
- September 2025 (date) — Reporting period
- Toronto, Ontario (location) — Company headquarters
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2025.
What was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. located?
The company's principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files or will file annual reports under cover of Form 20-F.
What is the SEC file number for Quantum Biopharma Ltd.?
The Commission File Number for Quantum Biopharma Ltd. is 001-39152.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-09-29 07:40:05
Filing Documents
- f6k_092925.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 27KB
- 0001171843-25-006107.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: September 29, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated September 29, 2025